Seropositivity of Anti-SARS CoV2 IgG antibodies in health care workers of an Indian tertiary care hospital during COVID-19COVID-19 기간 동안 인도 3차 의료 병원의 의료 종사자에서 Anti-SARS CoV2 IgG 항체의 혈청 양성Article Published on 2022-04-012022-09-11 Journal: Indian journal of medical microbiology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] Anti-COVID IgG antibodies antibody association Asymptomatic Asymptomatic case Asymptomatic cases Care Clinical data close contact COVID-19 Ct value Demographic and clinical data eight enrolled General population HCW HCWs Health care Health care worker health care workers higher risk hospital IgG antibody Infection patients with COVID-19 positive questionnaire rate of seroconversion respiratory respiratory sample RT- PCR RT-PCR SARS CoV2 SARS-CoV-2 IgG Sero-surveillance. Seroconversion Seropositivity serum sample serum samples statistically significant tested Viral was used [DOI] 10.1016/j.ijmmb.2022.02.004 PMC 바로가기 [Article Type] Article
Asymptomatic SARS-COV-2 carriage and sero-positivity in high risk contacts of COVID-19 cases’COVID-19 사례의 고위험 접촉자에서 무증상 SARS-COV-2 보균 및 혈청 양성'Article Published on 2022-04-012022-09-11 Journal: Indian journal of medical microbiology [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] anti-SARS-CoV-2 antibodies antibodies antibody antibody levels appearance Asymptomatic Asymptomatic COVID-19 blood sample Blood samples collected conducted Contact contribute Course COVID 19 COVID-19 COVID-19 case COVID-19 infection demographic demographic data Factor General population had no Health healthcare worker Healthcare workers high risk identify identifying India individual Infection infection control observation pandemic positive proportion rate of seroconversion real-time RT-PCR remained RNA RT-PCR SARS-CoV-2 antibodies SARS-COV-2 infection SARS-CoV-2 RNA SARS-CoV2 selected Seroconversion Seropositivity significantly higher significantly increased socioeconomic status subject subjects Swab Symptom Symptoms tested Viral were recorded [DOI] 10.1016/j.ijmmb.2021.12.012 PMC 바로가기 [Article Type] Article
Assessing humoral immune response after two doses of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthcare workers의료 종사자의 비활성화된 SARS-CoV-2 백신(CoronaVac) 2회 접종 후 체액성 면역 반응 평가Observational Study Published on 2022-04-012022-09-11 Journal: Public health [Category] COVID19(2023년), SARS, 임상, 진단, 치료기술, [키워드] Abbott absence age anti-Spike IgG antibody Assessing blood sample Blood samples CoronaVac COVID-19 pandemic cutoff value declined detection dose female first dose greater HCW HCWs healthcare worker Healthcare workers highest humoral immune response Humoral immunity Immunity immunoassay immunogenic immunogenicity Immunoglobulin Immunoglobulin G inactivated inactive Infection investigated Ireland male men Microparticle observational study performed positive prospective observational study receptor Receptor-binding domain reported risk S1 subunit SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 vaccine second dose second dose of vaccine Seropositivity significantly Spike protein susceptible the receptor-binding domain the S1 subunit the spike protein vaccination Vaccine virus was performed women [DOI] 10.1016/j.puhe.2022.01.011 PMC 바로가기 [Article Type] Observational Study
Persistently reduced humoral and sustained cellular immune response from first to third SARS-CoV-2 mRNA vaccination in anti-CD20-treated multiple sclerosis patients항CD20 치료 다발성 경화증 환자에서 1차부터 3차까지의 SARS-CoV-2 mRNA 백신 접종에서 체액성 면역 반응이 지속적으로 감소하고 세포 면역 반응이 지속됨Article Published on 2022-04-012022-09-11 Journal: Multiple sclerosis and related disorders [Category] COVID19(2023년), MERS, SARS, 바이오마커, 진단, [키워드] Abbott Abbott Laboratories administration All participant All participants allowance anti-CD20 anti-CD20 therapy Antibody Response B cell BNT162b2 BNT162b2 mRNA Booster vaccine CD20 CD4 CD8 Cellular immune response cellular response Cohort dropped frequencies Frequency humoral include longitudinal study median monoclonal antibodies mRNA vaccination mRNA vaccine Multiple multiple sclerosis no difference Ocrelizumab participant Patient PBMC peptide peptide pool Prophylactic reactive reduced reduction SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 IgG II Quant assay SARS-CoV-2 vaccination second vaccination seropositive Seropositivity Spike-specific T-cell responses Study design sustained T-cell T-cell Response T-cell responses T-cells T-lymphocyte treated vaccination was done were assessed were measured [DOI] 10.1016/j.msard.2022.103729 PMC 바로가기 [Article Type] Article
Study of immunogenicity, safety and efficacy of covishield vaccine among health care workers in a tertiary cardiac care centre3차 심장치료센터 의료진을 대상으로 한 covishield 백신의 면역원성, 안전성 및 유효성 연구Article Published on 2022-04-012022-09-12 Journal: Indian journal of medical microbiology [Category] COVID19(2023년), SARS, 진단, [키워드] acute respiratory syndrome Adverse Adverse events following immunisation (AEFI) average Breakthrough infection Care conducted coronavirus Covishield dose doses duration of symptom Efficacy event Fever HCWs Health care Health care worker Health care workers (HCWs) IgG antibody increase in interval local pain median value Mild pandemic participant post vaccination prevented reduced Research safety profile SARS-CoV-2 second dose Seropositivity severity Severity of infection Study participants Symptom uninfected vaccination Vaccine were assessed [DOI] 10.1016/j.ijmmb.2022.03.003 PMC 바로가기 [Article Type] Article
Dynamic observation of SARS-CoV-2 IgM, IgG, and neutralizing antibodies in the development of population immunity through COVID-19 vaccinationSARS-CoV-2 IgM, IgG, 중화항체의 코로나19 예방접종을 통한 집단면역 발달의 동적 관찰Article Published on 2022-04-012022-09-11 Journal: Journal of Clinical Laboratory Analysis [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] antibody Antibody responses assays assessment booster dose booster vaccination changes in chemiluminescent immunoassay CLIA convalescent Conventional conventional virus neutralization test coronavirus coronavirus disease coronavirus disease-2019 correlation COVID-19 COVID-19 convalescent COVID-19 vaccination COVID-19 vaccine criterion cVNT diagnostic discharge dynamic ELISAs enzyme-linked immunosorbent assay enzyme-linked immunosorbent assays evaluated FIVE foundation guide humoral immune response IgG IgM immune immune response Immunity include indicated individual NAb assay NAbs neutralization test Neutralizing neutralizing antibody observation Patient population immunity positive rate ranged Rapid reached receipt SARS-CoV-2 IgM SARS-COV-2 infection second dose Sensitivity and specificity serological seropositivities Seropositivity serum Serum neutralizing antibody specific IgM the antibody response vaccination Vaccine virus neutralization test Volunteer volunteers was used [DOI] 10.1002/jcla.24325 PMC 바로가기 [Article Type] Article
Antibody seroprevalence against SARS-CoV-2 within the Canton of Sarajevo, Bosnia and Herzegovina-One year later1년 후 사라예보, 보스니아 헤르체고비나 주 내 SARS-CoV-2에 대한 항체 혈청 유병률Article Published on 2022-03-312022-09-11 Journal: PLoS ONE [Category] MERS, SARS, 진단, 치료기술, [키워드] age anti-SARS-CoV-2 anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody antibody electrochemiluminescence immunoassay Frequency General population gradually increased group help highest inaccessible individual individuals local public health lowest measure median men Older Pandemics positive Prevalence PROTECT provided quantified Reinfection resource SARS-CoV-2 seropositive individual seropositive individuals Seropositivity Spread the vaccine the vaccines vaccination Vaccine development women [DOI] 10.1371/journal.pone.0265431 PMC 바로가기 [Article Type] Article
SARS-CoV-2 Seroprevalence Among Health Care Workers in Major Private and Public Hospitals With COVID-19 Patient’s Referral in Tehran, Iran이란 테헤란에서 COVID-19 환자 추천을 받은 주요 사립 및 공립 병원의 의료 종사자들 사이에서 SARS-CoV-2 혈청 유병률Article Published on 2022-03-242022-09-11 Journal: Frontiers in Public Health [Category] MERS, SARS, 진단, 치료기술, [키워드] 95% CI adjusted anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody antibody asked assistant Asymptomatic Blood Blood samples categories COVID-19 COVID-19 patient cross-sectional cross-sectional study demographic characteristics detect effort ELISA kits ELISA test FIVE HCW HCWs Health care Health care worker health care workers health-care health-care worker highest hospital Hospital staff hospitals IgG and IgM IgM antibodies Infection Iran janitor lowest Major medical history Nurse Nurses participant Participants Personal protective equipment positive PPE Prevalence Private Protective Public Public Hospital public hospitals question Randomly recruited Referral SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 ELISA SARS-CoV-2-specific IgG selected seropositive individual seropositive individuals Seropositivity Seroprevalence significantly higher Tehran test results tested Usage were used worker [DOI] 10.3389/fpubh.2022.832003 PMC 바로가기 [Article Type] Article
High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers에티오피아 의료 종사자들 사이에서 항 SARS-CoV-2 항체의 높은 혈청 유병률Article Published on 2022-03-162022-09-11 Journal: BMC Infectious Diseases [Category] SARS, 치료기술, [키워드] 95% CI adjusted odds ratio African analyzed anti-SARS-CoV-2 anti-SARS-CoV-2 antibody antibodies Antibody testing AOR association asymptomatic infection blood sample Blood samples Care Clinical data close contact collected combating Community Contact contact with COVID-19 COVID-19 case COVID-19 cases COVID-19 pandemic Demographic and clinical data Descriptive statistics determine develop ELISA enzyme enzyme-linked immunosorbent assay estimate Ethiopia Ethiopian exposure to Factors females FIVE General population guide had no Harar Health Health care Health care system health system healthcare worker Healthcare workers higher risk highest highlight hospitals house IgG Infection information Logistic regression lowest measure multivariate logistic regression no symptoms onset of symptom pandemic patients with SARS-CoV-2 potential risk Prevalence provided Public Hospital Ratio RBD Receptor binding domain Region SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2 seroprevalence sensitivity sera serology seropositive Seropositivity Seroprevalence serum sample serum samples specificity sub-Saharan Africa Symptom Symptoms Transmission virus were used with COVID-19 [DOI] 10.1186/s12879-022-07247-z PMC 바로가기 [Article Type] Article
Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients아달리무맙과 인플릭시맙은 SARS-CoV-2 항체 반응을 손상시킨다: 생물학적 치료를 받은 11,422명의 환자를 대상으로 한 치료 약물 모니터링 연구의 결과Article Published on 2022-03-142022-09-11 Journal: Journal of Crohn's & colitis [Category] MERS, SARS, 진단, 치료기술, 치료법, [키워드] adalimumab anti-TNF antibody reactivity Antibody Response Antibody testing attenuate biologic bowel causal relationship CLARITY combination therapy confounding factors COVID-19 cut-off detectable drug drug level drug levels drugs Immune-mediated inflammatory diseases immunomodulator Immunosuppression Inflammatory Inflammatory bowel disease Inflammatory diseases infliximab influence Laboratory magnitude median median age median time monitoring Necrosis Patient patients PCR testing PCR-confirmed positive Rate reactivity responses Result SARS-CoV-2 SARS-CoV-2 antibodies SARS-COV-2 infection SARS-CoV-2 nucleocapsid SARS-CoV-2 PCR seroconvert serological serological response seropositive Seropositivity Seroprevalence serum Support therapeutic drug Therapeutic Drug Monitoring treated Treatment treatment groups undetectable vaccination vedolizumab were measured [DOI] 10.1093/ecco-jcc/jjab153 PMC 바로가기 [Article Type] Article